Trade Mark Journal No.2026/035 28 August 2026
WO0000001932372 (5)
Office of origin: United States of America
Date of International Registration:14 July 2026
Date of designation in the UK:
14 July 2026

International priority date claimed: 13 July 2026
(United States of America)
(99936830)
- Class 5
- Pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of immune system related diseases and disorders.
Viridian Therapeutics, Inc.
Representative: Valerie Brennan Plave Koch PLC, 3120 Fairview Park Drive, Suite 420, Falls Church VA 22042, UNITED STATES OF AMERICA